We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AJG icon
9426
PUT
Arthur J. Gallagher & Co
AJG
$64.1B
-150,000
Closed -$37.5M
AKAN icon
9427
Akanda
AKAN
$2.87M
-5
Closed -$3.54K
ALB icon
9428
PUT
Albemarle
ALB
$13.9B
-332,200
Closed -$43.8M
ALGM icon
9429
CALL
Allegro MicroSystems
ALGM
$7.73B
-412,200
Closed -$11.1M
ALL icon
9430
CALL
Allstate
ALL
$68B
-49,000
Closed -$8.48M
ALLT icon
9431
Allot
ALLT
$372M
-965
Closed -$2.18K
ALNY icon
9432
CALL
Alnylam Pharmaceuticals
ALNY
$27.5B
-10,000
Closed -$1.49M
AMS icon
9433
American Shared Hospital Services
AMS
$9.94M
-3,815
Closed -$11.3K
ANEB
9434
DELISTED
Anebulo Pharmaceuticals
ANEB
-144
Closed -$413
ANEW icon
9435
ProShares MSCI Transformational Changes ETF
ANEW
$7.75M
-57
Closed -$2.37K
ANF icon
9436
CALL
Abercrombie & Fitch
ANF
$4.42B
-45,000
Closed -$5.64M
AOTG icon
9437
AOT Growth and Innovation ETF
AOTG
$96.9M
-98
Closed -$3.77K
APCXW
9438
DELISTED
AppTech Payments Corp Warrant
APCXW
-194
Closed -$64
APLM icon
9439
Apollomics
APLM
$37.9M
-75
Closed -$5.63K
APLY icon
9440
YieldMax AAPL Option Income Strategy ETF
APLY
$118M
-1,484
Closed -$25.5K
APO icon
9441
CALL
Apollo Global Management
APO
$72.4B
-5,000
Closed -$562K
APP icon
9442
CALL
Applovin
APP
$133B
-111,800
Closed -$7.74M
APPN icon
9443
CALL
Appian
APPN
$1.98B
-68,200
Closed -$2.72M
APT icon
9444
Alpha Pro Tech
APT
$50.4M
-4,515
Closed -$28.2K
ARKK icon
9445
CALL
ARK Innovation ETF
ARKK
$5.64B
-194,326
Closed -$9.73M
ARKK icon
9446
PUT
ARK Innovation ETF
ARKK
$5.64B
-142,500
Closed -$7.14M
ARTL icon
9447
Artelo Biosciences
ARTL
$2.68M
-7
Closed -$185
ARVR icon
9448
First Trust Indxx Metaverse ETF
ARVR
$5.39M
-46
Closed -$1.64K
ASPN icon
9449
PUT
Aspen Aerogels
ASPN
$384M
-200
Closed -$3.52K
ASTC icon
9450
Astrotech Corp
ASTC
$13.1M
-596
Closed -$5.33K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.